Comprehensive coverage

Endymed

Prof. Natan Kerin, Faculty of Medicine at the Technion

Biotechnology cluster: Glaxo-Smith-Kline and Biorap signed an agreement to develop a drug to prevent transplant rejection and to treat autoimmune diseases

  • No comments
Science website logo
SEARCH